文献速递重症综合管理与镇静镇痛复苏、休克与脓毒症

白细胞介素-35通过限制脓毒症中高迁移率族蛋白B1依赖的自噬下调效应CD4+ T细胞的免疫反应

INTERLEUKIN-35 DOWNREGULATES THE IMMUNE RESPONSE OF EFFECTOR CD4 + T CELLS VIA RESTRICTING HIGH MOBILITY GROUP BOX-1 PROTEIN-DEPENDENT AUTOPHAGY IN SEPSIS.
PubMed 文献 · Shock · 2022-09-26
一句话结论脓毒症小鼠中IL-35升高,重组IL-35通过限制HMGB1依赖的自噬抑制效应CD4+ T细胞增殖与Th1/Th2比值并缩短生存时间。

该研究在C57BL/6小鼠中采用盲肠结扎穿刺(CLP)诱导脓毒症,探讨抗炎细胞因子IL-35对效应CD4+ T细胞的作用。结果显示脓毒症小鼠血清和脾脏IL-35水平显著升高;CLP后给予重组IL-35进一步降低效应CD4+ T细胞增殖和Th1/Th2比值,并显著缩短生存时间。脓毒症诱导的自噬激活对效应CD4+ T细胞具有保护作用,而被重组IL-35阻断;体外激活的效应CD4+ T细胞中IL-35抑制自噬的作用由限制高迁移率族蛋白B1(HMGB1)转位介导。作者认为IL-35是脓毒症中损害CD4+ T细胞增殖与分化的免疫抑制性细胞因子,其作用可能通过减少HMGB1依赖的自噬实现。

要点

  • 脓毒症小鼠血清和脾脏IL-35水平显著升高。
  • CLP后给予重组IL-35进一步降低效应CD4+ T细胞增殖和Th1/Th2比值,并显著缩短生存时间。
  • 脓毒症诱导的自噬激活对效应CD4+ T细胞具有保护作用,该自噬被重组IL-35阻断。
  • IL-35抑制自噬的作用由限制HMGB1转位介导。
  • 作者认为IL-35是损害脓毒症CD4+ T细胞增殖与分化的免疫抑制性细胞因子。

适用人群与场景

  • C57BL/6小鼠,采用盲肠结扎穿刺(CLP)诱导脓毒症模型。

处置流程与药物剂量

  • CLP后给予重组IL-35(rIL-35);原文未写明剂量、途径和疗程。
  • 使用抗IL-35(EBI3)处理;原文未写明剂量、途径和疗程。

研究设计与关键结果

  • 研究类型:动物实验(C57BL/6小鼠CLP脓毒症模型)及体外激活效应CD4+ T细胞实验。
  • 脓毒症小鼠血清和脾脏IL-35水平显著升高。
  • CLP后给予重组IL-35进一步降低效应CD4+ T细胞增殖和Th1/Th2比值,并显著缩短生存时间。
  • 脓毒症诱导的自噬激活对效应CD4+ T细胞具有保护作用,并被重组IL-35阻断。
  • 体外激活的效应CD4+ T细胞中观察到IL-35抑制自噬,该作用由限制HMGB1转位介导。

证据类型、等级与局限

  • 证据类型:动物实验及体外细胞实验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为IL-35是脓毒症中损害CD4+ T细胞增殖与分化的免疫抑制性细胞因子,其作用可能通过减少HMGB1依赖的自噬实现。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Background: Immunosuppression is critically involved in the development of sepsis and is closely associated with poor outcomes. The novel role of the anti-inflammatory cytokine IL-35 in sepsis was examined. Methods: Sepsis was induced by in C57BL/6 mice cecal ligation and puncture (CLP). The impacts of IL-35 on effector CD4 + T cells were investigated by examining cell proliferation and the Th1/Th2 ratio in the presence of recombinant IL-35 (rIL-35) or anti-IL-35 (EBI3). The regulatory effect of IL-35 on autophagy was evaluated by measuring autophagy markers and autophagic flux in CLP mice in vivo and in activated effector CD4 + T cells in vitro . Results: IL-35 levels were significantly increased in the serum and spleens of septic mice. rIL-35 administration after CLP further decreased proliferation and the Th1/Th2 ratio in effector CD4 + T cells and significantly shortened the survival time. Sepsis-induced autophagy activation was protective in effector CD4 + T cells and was blocked by rIL-35. The inhibitory effect of IL-35 on autophagy was observed in activated effector CD4 + T cells in vitro , and this effect was mediated by restricting high mobility group box-1 protein (HMGB1) translocation. Conclusion: IL-35 is an immunosuppressive cytokine that impairs CD4 + T-cell proliferation and differentiation in sepsis, and the effect might be mediated by reducing HMGB1-dependent autophagy.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Wu T, Ren C, Dou X, et al. INTERLEUKIN-35 DOWNREGULATES THE IMMUNE RESPONSE OF EFFECTOR CD4 + T CELLS VIA RESTRICTING HIGH MOBILITY GROUP BOX-1 PROTEIN-DEPENDENT AUTOPHAGY IN SEPSIS. Shock. 2022. PMID: 36731088. doi:10.1097/SHK.0000000000001990

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。